Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of combined local and systemic anti-inflammatory adjuncts in vitrectomy with silicone oil for proliferative vitreoretinopathy
2004-001991-37Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Jul 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of triamcinolone acetonide, prednisolone and flurbiprofen in Proliferative Vitreoretinopathy (PVR), sponsored by Moorfields Eye Hospital. Primary endpoint: Primary anatomical outcome at 6 months after silicone oil removal. Started Jul 2005; status: completed.
02
Drugs
triamcinolone acetonideprednisoloneflurbiprofen
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on 2004-001991-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001991-37.